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Effects of Preformed Antibodies Induced by Whole Blood Transfusion 
on Small Bowel Transplantation 
S. FUjisaki, N. Murase, A.J. Demetris, M. Tanabe, S. Todo, and T.E. Starzl 
ALTHOUGH pretransplant donor-specific transfu-
sions (DSn have been effective in prolonging sub-
sequent allograft survival. alloreactive antibodies are also 
produced after sensitization with DST. The purpose of this 
study was to examine the inftuence of blood transfusion on 
small bowel transplantation (SBTx). 
MATERIALS AND METHODS 
Using inbred male LEW (RTl 1), BN CRTl"). ACI CRTI"). and 
PYG CRT! 0) rats weighing 200 to 300 g. orthotopic SBTx was 
periormed as described previously. I Donor-specific or third-party 
heparinized whole blood 0.0 mLl was given 7 days before 
transplantation. As a control. SBTx was periormed in untrans-
fused recipients. Furthermore. the effect of blood transfusion on 
the incidence of graft versus host disease (GYHDl was examined 
using LEW-to-BN SBTx, in which fatal GYHD occurs under 
FKS06 immunosuppression. l BN recipients received either LEW, 
PYG. whole blood. or no transfusion 7 days before LEW small 
bowel grafting. FKS06 (Fujisawa Pharm Co Ltd. Osaka. Japan) 
was given intramuscularly at a dose of 0.64 mglkgld for 14 
postoperative days. 
Serum samples for Iymphocytoto,uc antibody (LAb) assay were 
obtained from ACI rats 7 days after PYG blood transfusion. To 
investigate the specificity of the preformed LAbs induced by 
blood transfusion. the sera were further absorbed with donor 
(PYG) or syngeneic (ACI) red blood cells (RBCs). which are 
known to carry suriace class I mlYor histocompatibility complex 
(MHC) antigenic determinants. A complement fixing LAb assay 
was periormed using unfractionated donor or third·party strain 
lymphocytes as targets according to the method described previ-
ously.J 
In the LEW-ta-BN combination. percentages of donor cells in 
the recipient circulation were examined. Recipient peripheral 
blood lymphocytes were stained with monoclonal antibody (MAb) 
163. which is specific for the RTt.AI antigen on LEW (kindly 
provided by Dr H. W. Kunz. University of Pittsburgh. Depart· 
ment of Pathology) and were analyzed using a FACScan flow 
cytometer. 
Statistical analysis was pcriormed using the Mann-Whitney U 
test. 
RESULTS 
DST significantly (P < .05) prolonged the survival of PVG 
recipients of ACI grafts (median survival 14.0 days. n = 
12). LEW recipients of ACI grafts (median survival 16.5 
days. n = 6). and BN recipients of LEW grafts (median 
survival 25.5 days. n = 6) when compared with those 
without DST (median survival 7.5. 5.5. and 12.5 days. 
respectively; n = 6 for each group). However. in the 
LEW-to-ACI combination. animals with DST developed 
severe graft damage soon after transplantation and two of 
six (33.3%) animals died within 3 days. suggesting that 
antibody-mediated rejection occurred in these animals. 
Surprisingly. the same changes were observed when ACI 
animals transfused with third-party (PVG) blood received 
LEW intestinal grafts and three of six (50.0%) died within 
3 days. Similar results were obtained after PVG-to-ACI 
transplants. Six of eight (75.0%) recipients with DST and 
one of six (16.7%) recipients with third-party (LEW) blood 
transfusion died within 3 days. Macroscopically. early 
graft damage was observed in all animals; however. some 
animals that were able to recover from this early damage 
showed prolonged survival. 
LAb assay showed that sera from PVG blood transfused 
ACI rats were able to kill lymphocytes from donor (PVG) 
and all third-party strains (LEW. BN. and sm. When sera 
were absorbed with donor (PVG) RBCs to remove anti-
bodies against donor MHC class I. LAb titer was slightly 
reduced from 211 to 210 against donor (PVG) and from 210 
to 29 against third-party (LEW) lymphocytes. The same 
degree of decrease in LAb titer was also seen after 
syngeneic RBC absorption. suggesting that the reduction 
after RBC absorption was not significant and was caused 
by sample dilution during the procedure. 
All FK506-treated BN recipients of LEW grafts died of 
GVHD with a median survival of 32.0 days (n = 8). In 
contrast. when BN recipients received donor (LEW) and 
third-party (PVG) blood transfusion 7 days before grafting, 
animals did not show any signs of GVHD and survived for 
a median of 85.5 days (n = 12) and 92.0 days (n = 9), 
respectively. Four of 12 (33.3%) recipients pretreated with 
LEW blood transfusion and two of nine (22.2%) with PVG 
blood died of leakage or obstruction in intestinal anasto-
moses early after transplantation. These complications 
were thought to be an immunological event mediated by 
preformed antibodies. According to ftow cytometric anal-
ysis. circulating donor lymphocytes reached 10% in un-
transfused recipients 6 to 7 days after SBTx. but donor or 
third-party blood transfusion totally eliminated donor lym-
phocytes from the circulation. These findings explained 
the absence of GVHD in blood-transfused animals. 
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DISCUSSION 
Although LAb production after blood transfusion has been 
described,1.4 damage caused by these antibodies was not 
reported after heart, kidney. or liver transplantation. 3,$.6 
This study shows that hyperacute rejection of small bowel 
grafts occurs not only in donor-specific blood-transfused 
recipients. as reported by Gundlach et al.$ but also in 
third-party blood-transfused recipients. Results of in vitro 
LAb assay confirm that antibodies produced in blood-
transfused animals are not blood donor MHC class I 
specific and are cytotoxic to lymphocytes from many rat 
strains. LAbs induced by blood transfusion have been 
shown to be of both IgG and IgM class and have low 
affinity to kidney and liver tissues.3,4 However. this study 
s~ggests that they may have high affinity to the lymphoid-
nch small bowel graft. 
A distinctive feature of small bowel grafts is the exis-
tence of specialized endothelial cells lining the high endo-
theli~ venules (HEV) in lymph nodes and Peyer's patches. 
Specific cell-ta-cell recognition systems between lympho-
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cytes and endothelial cells of HEV mediate migration of 
lymphocytes from the bloodstream to lymphoid tissues. 
LAbs produced by blood transfusion may have direct 
reactivity to endothelial cells of HEV. 
The nature of antibodies induced by blood transfusion 
and the mechanisms of damage seen only in small bowel 
graft are under investigation. 
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